Denali Therapeutics Inc.

DNLI· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$20.13+0.35%

2026-09-17

Financials

Valuation Metrics

Denali Therapeutics Inc.'s Market Cap is $3.19B. At end of 2025 it was $2.90B. Ranked #1687 of 3,121 in US market (top 54%), #604 of 1,463 on NASDAQ (top 41%), #103 of 266 in Pharmaceuticals, Biotechnology & Life Sciences (top 39%) by Market Cap.

Investment Metrics(as of 2026-09-18)

Metric	Value	Rank
Size
Market Cap	$3.19B	US#1,687/3,121 Sec#103/266
Revenue	$4M	US#2,858/3,121 Sec#183/266
Net Income	$-511M	US—/3,121 Sec—/266
Total Assets	$1.16B	US#2,411/3,121 Sec#91/266
Net Assets	$835M	US#1,889/3,121 Sec#78/266
Value
P/B	3.83x	US#1,983/3,121 Sec#111/266
P/S	886.47x	US#2,986/3,121 Sec#197/266
FCF Yield	-13.69%	US—/3,121 Sec—/266
Profitability
ROE	-61.24%	US#2,723/3,121 Sec#174/266
ROA	-44.17%	US#2,964/3,121 Sec#196/266
Op. Margin	-15058.19%	US#2,876/3,121 Sec#189/266
Financial Health
Debt Ratio	38.65%	US#440/3,121 Sec#128/266
Total Debt	$28M	US#2,710/3,121 Sec#180/266
FCF	$-437M	US#2,892/3,121 Sec#249/266
Cash	$202M	US#1,734/3,121 Sec#109/266
Current Ratio	8.37x	US#310/3,121 Sec#94/266
Performance
1Y Return	54.13%	US#527/3,121 Sec#104/266
1M Return	-17.19%	US#2,902/3,121 Sec#233/266
From 52W High	-26.26%	US#1,853/3,121 Sec#142/266
1Y MDD	-26.28%	US#1,143/3,121 Sec#62/266
Trading
Volume	1,366,923 shares	US#1,135/3,121 Sec#115/266
Trading Value	$28M	US#1,663/3,121 Sec#126/266
Per Share
EPS	$-3.22	US—/3,121 Sec—/266
BPS	$5.26	US#2,266/3,121 Sec#126/266